Drug firm ends conference payments

By The Press Association2013-12-19T10:11:00

Drugs giant GlaxoSmithKline will stop paying for doctors to attend medical conferences and scrap some sales targets as it seeks to mend its reputation in the wake of a damaging scandal over multimillion-pound bribery claims in China.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here